Aurobindo Pharma to buy Sandoz US’ dermatology and oral solids businesses

(adsbygoogle = window.adsbygoogle || []).push({}); Aurobindo Pharma has agreed to acquire the dermatology business and a portfolio of oral solid products along with commercial and manufacturing infrastructure from Sandoz US, a division of Novartis, in a deal worth about $1 billion. In this regard, the Indian pharma company will pay Sandoz More...

by businessnewstoday | Published 1 month ago
By Soujanya Ravi On Friday, August 24th, 2018

Novo Nordisk acquires glucose binding molecules developer Ziylo

Novo Nordisk acquisition of Ziylo : Danish pharma company Novo Nordisk  has acquired Ziylo, a University of Bristol spin-out biotechnology company, in a deal that could cross $800 million to support its goal to More...

By businessnewstoday On Wednesday, July 25th, 2018

Cambrex acquisition of Halo Pharma : US CDMO to be acquired for $425m

Cambrex acquisition of Halo Pharma : Cambrex has made a $425 million deal to buy US-based contract development and manufacturing organization (CDMO) Halo Pharma to gain entry into the large and finished dosage form More...

By businessnewstoday On Sunday, July 1st, 2018

CVC to acquire €3.03bn worth stake in Italian pharma company Recordati

Pharma acquisition news : CVC Capital Partners through its CVC Fund VII has led a consortium of funds to acquire a stake of 51.8% in Recordati, an Italian pharma company in a deal worth around €3.03 billion. The More...

By businessnewstoday On Sunday, June 24th, 2018

Lilly wraps up acquisition of immuno-oncology company Armo BioSciences

Pharma acquisition news : US pharma firm Eli Lilly and Company (Lilly) has completed its $1.6 billion acquisition of Armo BioSciences, a California-based late-stage immuno-oncology company. Armo BioSciences is focused More...

By businessnewstoday On Saturday, April 21st, 2018

Takeda offers $62bn to acquire Irish rare disease company Shire

Japanese pharma company Takeda Pharmaceutical has proposed to acquire Shire, an Ireland-based rare disease company for $62 billion after Botox-maker Allergan scrapped its plans of making a rival bid. Friday’s More...

By businessnewstoday On Thursday, April 19th, 2018

Procter & Gamble to acquire Merck’s consumer health business for €3.4bn

P&G acquisition of Merck consumer health business : US consumer goods company Procter & Gamble (P&G) has agreed to acquire German pharma company Merck’s consumer health business in an all-cash deal More...

By businessnewstoday On Monday, April 16th, 2018

French pharma company Servier to acquire Shire oncology business for $2.4bn

Pharma acquisition news : French pharma company Servier Laboratories has made a $2.4 billion all-cash deal to acquire the oncology business of Irish biotech company Shire. Servier acquisition of Shire oncology business More...

By businessnewstoday On Sunday, April 15th, 2018

Sanofi announces $396m vaccine manufacturing facility in Toronto

French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at the Canadian headquarters of its vaccine business unit More...

By businessnewstoday On Saturday, April 14th, 2018

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused on developing drugs for rare More...